MEDIUM DERIVED FROM STEM CELLS AS A PHARMACEUTICAL COMPOSITION
    1.
    发明申请
    MEDIUM DERIVED FROM STEM CELLS AS A PHARMACEUTICAL COMPOSITION 审中-公开
    从干细胞衍生的中间体作为药物组合物

    公开(公告)号:WO2010043847A1

    公开(公告)日:2010-04-22

    申请号:PCT/GB2009/002350

    申请日:2009-10-02

    CPC classification number: A61K35/12

    Abstract: The invention provides an apoptosis-modulating cell-free composition comprising conditioned extracellular medium of a stem cell and uses thereof, particularly therapeutic uses. Also provided is a method of obtaining such a composition and an in vitro method of modulating apoptosis.

    Abstract translation: 本发明提供了一种细胞凋亡调节无细胞组合物,其包含干细胞的调节细胞外培养基及其用途,特别是治疗用途。 还提供了获得这样的组合物和调节凋亡的体外方法的方法。

    Methods of treatment
    4.
    发明专利

    公开(公告)号:GB9824436D0

    公开(公告)日:1999-01-06

    申请号:GB9824436

    申请日:1998-11-06

    Applicant: HABIB NAGY A

    Abstract: The use of an implantable pump in the treatment of a condition characterised by inadequate fluid flow, in vivo, in or through a vessel, channel or conduit, is disclosed. This comprises inserting said implantable pump into said vessel, channel or conduit and causing it to operate when required. Control is preferably by telemetric means. Conditions susceptible to treatment in this way include urinary incontinence, pulmonary hypertension and inadequate pulmonary ventilation.

    Conditioned medium from Omnicytes for anticancer therapy

    公开(公告)号:GB2464200A

    公开(公告)日:2010-04-14

    申请号:GB0917359

    申请日:2009-10-02

    Abstract: The conditioned medium from ECACC 04092401 Omnicytes, which are CD34+, wherein that medium comprises apoptosis modulating agents. Preferably the medium is for therapeutic use in the treatment of a hyperproliferative disorder such as skin disorders or cancer and particularly non-small cell lung carcinoma. The conditioned medium may have activity to promote the apoptosis of rapidly dividing cells or to promote the survival of slowly dividing cells and its activity is blocked by TNF-alpha blocking antibodies. Also disclosed is conditioned medium from other stem cells, particularly CD34+ stem cells having pluripotency and the ability to adhere plastic, for therapeutic use in the treatment of cancers and hyperproliferative disorders and in vitro use for apoptosis activation or inhibition.

    Treatment using implantable devices

    公开(公告)号:GB9816012D0

    公开(公告)日:1998-09-23

    申请号:GB9816012

    申请日:1998-07-22

    Abstract: A method of treatment using implantable devices is disclosed. he method comprises (a) implanting into the body of the human or non-human animal (i) a rectenna capable of receiving electromagnetic radiation in the microwave frequency range and of generating and/or storing electrical energy therefrom, and (ii) an electrically operated therapeutic device arranged to electrical energy from said rectenna; and (b) directing electromagnetic radiation in the microwave frequency range from a source external to the body being treated towards the position of the implanted rectenna so as to genera electrical energy to actuate said therapeutic device.

    Pharmaceutical composition
    7.
    发明专利

    公开(公告)号:GB0917359D0

    公开(公告)日:2009-11-18

    申请号:GB0917359

    申请日:2009-10-02

    Abstract: The invention provides an apoptosis-modulating cell-free composition comprising conditioned extracellular medium of a stem cell and uses thereof, particularly therapeutic uses. Also provided is a method of obtaining such a composition and an in vitro method of modulating apoptosis.

    Pharmaceutical composition
    8.
    发明专利

    公开(公告)号:GB0818725D0

    公开(公告)日:2008-11-19

    申请号:GB0818725

    申请日:2008-10-13

    Abstract: The invention provides an apoptosis-modulating cell-free composition comprising conditioned extracellular medium of a stem cell and uses thereof, particularly therapeutic uses. Also provided is a method of obtaining such a composition and an in vitro method of modulating apoptosis.

Patent Agency Ranking